Storm Therapeutics

Description: STORM Therapeutics develops first-in-class drugs targeting RNA epigenetics for oncology, backed by £30M funding from top investors.

Country: UK

Based in: Cambridge, Cambridgeshire

Founded: 2015

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Medical', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.